Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to -$9.0 million.

  • iBio's Income from Continuing Operations fell 10607.24% to -$9.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$24.7 million, marking a year-over-year decrease of 6238.02%. This contributed to the annual value of -$18.4 million for FY2025, which is 1176.18% down from last year.
  • As of Q4 2025, iBio's Income from Continuing Operations stood at -$9.0 million, which was down 10607.24% from -$5.7 million recorded in Q3 2025.
  • In the past 5 years, iBio's Income from Continuing Operations ranged from a high of -$3.2 million in Q2 2024 and a low of -$10.6 million during Q4 2022
  • Its 5-year average for Income from Continuing Operations is -$6.3 million, with a median of -$5.8 million in 2021.
  • In the last 5 years, iBio's Income from Continuing Operations crashed by 18508.9% in 2021 and then skyrocketed by 5751.21% in 2023.
  • iBio's Income from Continuing Operations (Quarter) stood at -$7.2 million in 2021, then tumbled by 46.79% to -$10.6 million in 2022, then soared by 57.51% to -$4.5 million in 2023, then grew by 2.76% to -$4.4 million in 2024, then crashed by 106.07% to -$9.0 million in 2025.
  • Its Income from Continuing Operations was -$9.0 million in Q4 2025, compared to -$5.7 million in Q3 2025 and -$5.2 million in Q2 2025.